Featured Content

Insurance Plans Dropping Coverage of FDA-approved BRCA Diagnostic Test

Some health care insurers have stopped covering this FDA-approved genetic test, instead limiting coverage only for cheaper, lower-quality genetic tests.

ASCO and SGO Issue New Guidelines for Treating Ovarian Cancer

ASCO and the Society of Gynecologic Oncology jointly issued new clinical practice guidelines for the treatment of patients with ovarian cancer.

Is BRCA1/2 Genetic Counseling by Telephone Inferior to a Face-to-face Interaction?

Telephone interviews to deliver genetic counseling may be non-inferior to in-person counseling.

Multi-gene Testing Increases Complexity of Counseling Women at Risk of Breast and Ovarian Cancer

Data sharing and increased pools of data are promising for prevention and early diagnosis of breast cancer and ovarian cancer.

More Features>>>

Gynecologic Cancers News

Gynecologic Cancers Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Cancer Therapy Advisor Articles